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Abstract: Development of the nervous system undergoes important transitions, including one
from neurogenesis to gliogenesis which occurs late during embryonic gestation. Here we report on
clonal analysis of gliogenesis in mice using Mosaic Analysis with Double Markers (MADM) with
quantitative and computational methods. Results reveal that developmental gliogenesis in the cerebral
cortex occurs in a fraction of earlier neurogenic clones, accelerating around E16.5, and giving rise to
both astrocytes and oligodendrocytes. Moreover, MADM-based genetic deletion of the epidermal
growth factor receptor (Egfr) in gliogenic clones revealed that Egfr is cell autonomously required for
gliogenesis in the mouse dorsolateral cortices. A broad range in the proliferation capacity, symmetry of
clones, and competitive advantage of MADM cells was evident in clones that contained one cellular
lineage with double dosage of Egfr relative to their environment, while their sibling Egfr-null cells
failed to generate glia. Remarkably, the total numbers of glia in MADM clones balance out regardless
of significant alterations in clonal symmetries. The variability in glial clones shows stochastic patterns
that we define mathematically, which are different from the deterministic patterns in neuronal clones.
This study sets a foundation for studying the biological significance of stochastic and deterministic
clonal principles underlying tissue development, and identifying mechanisms that differentiate
between neurogenesis and gliogenesis.
Keywords: cerebral cortex; clonal analysis; neurogenesis; gliogenesis; Egfr; astrocyte; oligodendrocyte
MADM; stochastic; deterministic
1. Introduction
Mechanisms that regulate the equilibrium between stem cell expansion and differentiation are
critical to balanced production of neurons and glia for homeostatic brain function. Neurogenesis in
the cerebral cortex may yield finite numbers of neurons governed by a deterministic clonal rule [1].
Accordingly, cortical progenitor cells generate prescribed and predictable numbers of neurons in a
precise window during embryonic development. This differs from regenerating tissues that maintain
progenitors throughout adulthood (e.g., skin, liver, lung epithelium and the gastrointestinal tract),
where the balance between expansion and differentiation at the level of individual clones appears
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stochastic [2–5]. Curiously, dynamics of expansion and differentiation at the level of total cellular
populations within these tissues balance out in predictable patterns (i.e., total number of cells produced,
maintenance of lineage patterns, and ultimately the shape of the tissue they form). In this context,
the cortex loses its ability to regenerate after embryogenesis, suggesting that clonal rules may be
different in organs that fail to regenerate during adulthood versus continuously regenerating tissues.
Gliogenesis begins during late neurogenesis, is a critical aspect of brain homeostasis, and unlike
neurogenesis it remains active and responsive to injury and disease for life [6–10]. Mature glial cells
comprise major subtypes based on their function, morphology and embryonic origins. Macroglia are
distinct from microglia in their ontogeny; macroglia are generated from CNS progenitors (neuroectodermal
origin), whereas microglia are derived from the hematopoietic system (mesodermal derived) around
midgestation [11]. Macroglia consist of astrocytes and oligodendrocytes, which are distributed
throughout the white and grey matters of the mature brain, are regionally and molecularly
diverse [12–14], and act as supporting cells for various neural networks. Only a few studies have
addressed the clonal aspects of gliogenesis, some focusing largely on oligodendrocyte production [15],
while others have focused on astrocytogenesis [16–20]. These studies reported on widespread
clones, which the investigators interpreted as heterogeneous in their origin and possibly function.
However, the imprecise and invasive nature of the broadly used embryonic electroporation or viral
infection approaches in the past studies, and the high density of labeled cells in the cortex with these
methods, leave their interpretive power regarding clonality of cells limited.
Here we report on a detailed analysis of gliogenesis during various stages of embryonic
development at a single postnatal time point in mice. To test the effects of disrupting gliogenesis
on overall neuronal and glial clones, we focused on manipulating the expression of the epidermal
growth factor receptor (Egfr). While developmental function of Egfr has been studied in various
contexts since the first report on its germline deletion [21] (these mice are perinatal lethal), its precise
role in the development of the CNS remains unclear. Gliogenesis is certainly under the influence
of Egfr and its predominant ligand Egf during perinatal development [22–25]. While a number of
studies have implicated Egfr signaling in oligodendrocyte development within the forebrain [24–29],
we and others have suggested a role in astrocyte production [30–33], and in neurogenesis and
neuronal survival [23,34,35]. Thus, Egfr’s role in gliogenesis and neurogenesis remains unclear and no
information is available on its functions at the clonal level.
2. Materials and Methods
2.1. Animals
Mice were used under the regulations and approval from the Institutional Animal Care
and Use Committee at North Carolina State University. Mice were housed in a 12-h light:dark
cycle with ad libitum access to food and water. Mice for mosaic analyses were generated using
breeding schemes that have been previously described [36]. Briefly, Egfr floxed mice [37] were
bred to Mosaic Analysis with Double Markers (MADM)-11TG mice (Igs2tm2(ACTB-TdTomato,-EGFP)Luo/J,
The Jackson Laboratory, Bar Harbor, USA; #013751) to generate EgfrF/F; MADM-11TG/TG mice via meiotic
recombination. MADM-11GT/GT mice (Igs2tm1(ACTB-EGFP,-tdTomato)Luo/J, The Jackson Laboratory, #013749)
were bred to Nestin-creERT2 mice (Tg(Nes-cre/ERT2)1Fsh) to generate Nestin-creER; MADM-11GT/GT
mice. For experiments, EgfrF/F; MADM-11TG/TG mice were crossed to MADM-11GT/GT mice with
the Nestin-creERT2 allele. Control mice were generated by crossing Nestin-creERT2; MADM-11GT/GT
mice to MADM-11TG/TG mice. Egfr floxed mice were genotyped for the presence of the wild type
(WT) and floxed alleles using the primers: Egfr lox3 F: 5′ CTTTGGAGAACCTGCAGATC; Egfr lox3
R: 5′ CTGCTACTGGCTCAAGTTTC. All other mouse lines (MADM alleles and Nestin-creERT2)
were genotyped using protocols provided by Jackson Laboratories. For induction of cre-mediated
recombination, Tamoxifen (TAM; Millipore Sigma, St. Louis, USA, 10 mg/mL in corn oil) was
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administered to timed pregnant dams at 50 micrograms/gram body weight by oral gavage via plastic
feeding tube (Instech, Plymouth Meeting, USA).
2.2. Tissue Processing and Immunohistochemistry
Pregnant dams were sacrificed by Avertin overdose (2,2,2 tribromoethanol; 7.5 mg/g body weight)
followed by cervical dislocation around E20 just prior to birth and embryos were extracted and
transferred to a surrogate female. Pups were allowed to survive to postnatal day 30 (P30) when they
were perfused with 4% paraformaldehyde (PFA) in phosphate buffer saline (PBS, 0.1 M, hereafter),
and brains were dissected and submerged in 4% PFA in PBS at 4 ◦C overnight. Brains were embedded
in 3% low melting point DNA-grade agarose in PBS and serial 50 µm sections were collected using a
vibratome (Leica VT1000S, Leica, Buffalo Grove, USA).
Floating serial sections were washed with PBS and blocked for 1 h at room temperature in blocking
buffer (10% normal donkey or goat serum, 1% Triton X-100, PBS). Sections were incubated with
primary anti-GFP (Abcam, Cambridge, MA; ab13970, 1:2000) and Rabbit anti-RFP (Abcam, ab62341,
1:500) antibodies diluted in 0.1% blocking buffer overnight at 4 ◦C, followed by 3 5-min washes with
PBS at room temperature the next day. AlexaFluor goat anti rabbit Cy3 (Thermo Fisher Scientific,
Waltham, USA; A10520, 1:1000), AlexaFluor goat anti-chicken 488 (Thermo Fisher Scientific, A11039,
1:1000) secondary antibodies were diluted in blocking buffer and incubated with the serial sections
for 1 h at room temperature, followed by 3 washes with PBS. Sections were counterstained with
the DNA marker (4′,6-diamidino-2-phenylindole; DAPI) at 1:2000 during the secondary incubation.
Sections were mounted onto glass slides and coverslipped with Faramount aqueous mounting medium
(Dako, Agilent Technologies, Santa Clara, USA). Images were acquired using an FV1000 confocal
microscope (Olympus, Waltham, USA).
2.3. Quantifications and Statistical Analyses
Captured clones were analyzed by counting the number of red and green cell types in the cortical
parenchyma in serial confocal images. Counts were restricted to dorsolateral motor, somatosensory,
and parietal cortices (including areas MOs, MOp, SSp, SSs, PTLp annotated in the Allen Brain Atlas,
https://mouse.brain-map.org/experiment/thumbnails/100048576?image_type=atlas). Counts were
recorded in Excel and standard statistical methods were employed for general analyses. Categorization
of clones by type and symmetry and subsequent statistical tests between categories of clones were
performed in MATLAB (version R2018a; MathWorks, Natick, USA). Clone types were assigned using
logical indexing to identify which clones had zero glia (N), zero neurons (G), or positive numbers of
both cell types (Mix). For symmetry categories in neural-containing clones, logical indexing was used
to identify which clones had >3 neurons in both red/green lineages (symmetric), 1–3 neurons in one
lineage and >3 neurons in the other lineage (two-sided asymmetric), or 1–3 neurons in both lineages
(small). A similar process was performed for glia in glia-containing clones. One-sided asymmetric
clones were identified with logical indexing to find whether the sum of red cells or sum of green cells
in a clone was equal to zero. A portion of Mix clones did not fall into any of these categories—these
clones had neurons in only one MADM lineage and glia in the other MADM lineage (or in both
colors). These clones fail to be categorized as one-sided since they have cells in both red and green
lineages, despite having zero neurons or zero glia on one side. We opted to groups these clones into
the two-sided asymmetric category since their production of neurons or glia is asymmetric but their
overall composition is not restricted to one color.
All data were presented as numbers of cells per clone, or as mean and standard error of the
mean (sem). Significance was evaluated by Student’s t-tests, univariate ANOVA, Wilcoxon Rank-sum,
and Chi square tests with p-values of less than or equal to 0.05 considered significant.
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2.4. Computational Models
Two types of models from previous studies were used as a basis for identifying deterministic or
stochastic patterns in the distributions of neurons or glia per clone. One study found that asymmetrically
differentiating progenitors produced a normally distributed number of neurons (averaging ~8 neurons
per clone), yielding a population-level multi-Gaussian distribution with peaks at integer multiples of




∣∣∣∣→p ) = ∑kj=1 β2j N(i∣∣∣∣ jµ0, σ2j ), (1)
which, due to the nature of the clonal expansion, was described as “deterministic” [1]. Here, k is the
number of Gaussians in the model,
→






, β2j < 1 is a positive weight,
and N(i
∣∣∣∣ jµ0, σ2j ) is a normal distribution with mean jµ0 and variance σ2j evaluated at integers i.
Neural production can also be modeled using a Galton–Watson stochastic branching process [38]
in which the two offspring of a dividing progenitor are randomly determined according to probabilities
p (of producing two neurons) and q (of producing two progenitors); thus 1− p− q is the probability of
producing one neuron and one progenitor. This type of stochastic process produces a distribution of
clone sizes where the probability of a clone of size n is




QkQn−k + (1− p− q)Qn−1, n ≥ 4 (3)
which resembles a geometric distribution whose shape is dependent on p and q [38].
In addition to these existing models, we formulated two new models for quantitative analysis of
glial clone sizes (https://repository.lib.ncsu.edu/handle/1840.20/38042). First, expanding upon the prior
stochastic model [38], we formulated a stochastic branching process model with two stages of clonal
expansion. This extension represents a stochastic clonal mechanism involving a progression from
progenitors to intermediate progenitors (IP) to glia. Here, a progenitor produces another progenitor
and an IP offspring according to probabilities p1 and q1, where the former is the probability of producing
two IPs and the latter is the probability of producing two progenitors; thus 1− p1 − q1 is the probability
of producing one IP and one progenitor. IP cells then divide to produce IPs and glia in a similar
manner; here p2 is the probability of producing two glia, q2 is the probability of producing two IPs,
and 1− p2 − q2 is the probability of producing one IP and one glial cell. We derived a similar formula




Qmn , n ≥ 4 (4)
where













where m is the number of IP cells produced from the initial progenitor. A maximum value of m = 16
was used to model the switch from progenitors to IPs in relatively few generations. If m > 16, at least




∣∣∣∣→p ) = ∑kj=1 β2j N(i∣∣∣∣µ j, σ2j ). (6)
The second new model extends MCON above, relaxing the requirement of equally spaced peaks,
This model was formulated primarily for hypothesis testing purposes, noting that MCON is
nested within MUNCON, and thus the two models can be compared to one another using an F-test [39].
Specifically, we were able to test whether relaxing the constraint of equally spaced peaks produces a
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better fit to the distribution of clone sizes, thus supporting or negating attribution of the deterministic
mechanism proposed in Gao et al. [1] to glia. Alternative mechanisms consistent with unequally
spaced peaks were not immediately identifiable, but a couple of possibilities exist. For instance,
glial production could be Gaussian but multi-modal, pointing to multiple deterministic patterns.
Alternatively, a combination of stochastic and deterministic behaviors could be present, which would
obscure the regularity of the Gaussian peaks.
3. Results
3.1. Astrocytic Clones Are Responsive to Dosage of Egfr in Dorsolateral Cortices at P30
To conduct clonal analysis of gliogenesis in vivo without the use of invasive approaches, we used
sparse labeling of progenitors at clonal densities in mice with Mosaic Analysis with Double Markers [36]
enabled on the mouse chromosome 11 (MADM-11) [40,41]. MADM operates through two reciprocal
chimeric reporter genes inserted near centromeric regions of chromosomes (here mouse chromosome
11; Figure 1a). Cre-mediated interchromosomal recombination events result in definitive labeling of
cells at low densities with two segregation patterns. EGFP (green) and tdTomato (red) expressing cells
originate from one type of division whereas yellow and non-fluorescent siblings are derived from
another type of division (Figure 1a).
To achieve Egfr deletion in MADM neural progenitor clones, we used two sets of MADM mice;
one where all MADM labeled cells are wild type (WT; iNes:MADM:Egfr +/+ mice referred to as +/+
herein), and another in which a floxed Egfr allele is crossed into the MADM background resulting in
siblings with differential dosages of Egfr by carrying WT (tdTomato+, red), heterozygous (Egfr- het;
tdTomato+/EGFP+, yellow), and homozygous (Egfr-null; EGFP+, green) floxed alleles of Egfr at low
densities (iNes:MADM:Egfr F/+, referred to as F/+ herein, Figure 1a). A Nestin-creERT2 transgenic
mouse [42] was used to induce the labeling of MADM clones in a temporally defined manner during
the gliogenic period using tamoxifen (TAM) injections in time-pregnant dams. Pups were allowed to
survive to postnatal day 30 when the analysis of clones was conducted in serial brain sections (P30;
Figure 1b). Because the MADM recombination event results in permanent labeling of the daughter
cell and its progeny from subsequent cell divisions, we were able to unambiguously track genetically
manipulated cells and fate specification in clonally derived daughter cells at postnatal day 30 (P30;
Figure 1b). Due to the presence of a single Egfr floxed allele in all cells of F/+ mice, we assume the
presence of a population of unlabeled Egfr-het cells that are intermingled with the MADM-labeled cells
(Figure 1a). MADM-11 animals without the floxed allele for Egfr were used as controls (+/+ mice;
all three combinations of reporter+ cells are WT).
We focused on clones containing green (Gfp+) and red (tdTomato+) MADM cells as they inform
on symmetry of clonal expansion under WT conditions in +/+ mice, as well as containing an Egfr
dosage model in F/+ cortices. Cells were counted in a total of 439 +/+ clones and 203 F/+ clones and
phenotyped as either neurons or glia based on morphological characteristics (Figure 2a). Counting was
restricted to clones in the dorsolateral cortices to avoid regional, developmental, and structural
variabilities across cortical areas. Analyses were confined to clonal cell counts in the upper and deep
layers (layers 1–6) of the cortex and do not include data from the underlying white matter (WM)
and the subependymal zone (SEZ), which contain complex sets of cells including active neural and
glial progenitors at P30. In a fraction of clones where we conducted a detailed survey of cell types
including the SEZ/WM (40 clones per induction time, per genotype), the majority of cells in upper
and deep layers of the cortex were astrocytes (Figure S1). Only a few oligodendrocyte-containing
clones in the +/+ brains were found in the deepest parts of layer 6 (percentages of all clones at each
induction age: 10.9% at E11.5, 0% at E15.5, 0% at E16.5, 2.2% at E17.5; Figure S1). These fractions
were elevated in the SEZ/WM where robust numbers of oligodendrocyte precursors reside (17.4% at
E11.5, 32.6% at E15.5, 39.1% at E16.5, 28.3% at E17.5; Figure S1). A very small portion of clones also
contained ependymal cells which often appeared as pairs of red and green MADM cells (Figure S1),
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suggesting their likely derivation from a terminal differentiative symmetric division. The fractions
of oligodendrocytes in the F/+ cortices were mostly similar to those in the +/+ cortices across the
different induction times (Figure S1). Thus, the majority of cells labeled as “glia” in this study are
astrocytes in the cortical layers II–VI. Details on the SEZ/WM cells, and additional characterization of
subclasses of astrocytes in the cortical layers, requires further classifications with the aid of molecular
markers (subject of a separate study). Nevertheless, within the cortical plate (layers 1–6) several
combinations were observed (Figure S2). At E11.5, purely neuronal clones were present while they
became less prevalent at E15.5–E17.5. Moreover, neuron plus oligodendrocyte containing clones
were only present in E11.5 clones, but not the others. Purely astrocytic clones emerge at E15.5–E17.5,
while we failed to observe any clones only containing oligodendrocytes within the cortical plate at any
time point. F/+ cortices contained similar distributions of cells (when red and green cells are combined),
although their proportions were changed. For example, astrocyte-containing clones became far more
abundant in F/+ cortices compared to +/+ clones (Figure S2).
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Figure 1. Clonal Analysis of Gliogenesis using Mosaic Analysis with Double Markers (MADM).
(a) Molecular basis of labeling individual progenitor clones with distinct fluorescent reporters
(GFP, green and tdTomato, red). Cre mediated interchromosomal mitotic recombination is followed
by two distinct segregation patterns (x-seg and z-seg) generating clonal siblings in distinct colors as
indicated. In control MADM mice, all cells will be WT and referred to as +/+. When a single floxed
allele for Egfr is introduced, green cells lack Egfr (Egfr-null), while the red cells are maintained as
WT (F/+ mice). Background genotypes obtained from the described genetic combinations using a
tamoxifen induced Nesti -creERT2 transgene result in substantial diff rences in the Egfr genotype
in ba kground cells (non-MADM rec mbinati events) which exert non-autonomous ffects on
MADM cells. (b) Schematic of amoxifen (TAM) induction ti points during embryonic development,
and processing of forebrains in serial sections. Inductions were performed in iNes:MADM:Egfr +/+ (+/+)
and iNes:MADM:Egfr F/+ (F/+) mice, which result in the generation of clones containing green and red
cells that become distinguished following TAM inductions. Green MADM F/+ glia (Egfr-null) fail to
develop, while glial production is elevated in the red sibling’s population. (c) Confocal images of a rare
symmetric “G” cortical clone in an E16.5 induced +/+ cortex. SEZ/WM, subependymal zone/white
matter; DL, deep layers; UL, upper layers. Scale bar, 100 µm.
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Figure 2. Glial subtypes in MADM clones. (a) Samples representing classified cell types in both red
and green MADM cells. Scale bars, 10 µm. (b) Maps of cell type distributions in the cortex of +/+ and
F/+ mice at different induction time points. Scale bars, 100 µm. (c) Plots of clone sizes (number of total
cells) in the green and red clonal populations in the cortex at P30 under various induction time points.
Each dot represents individual clones and averages are depicted ± sem. *, Student’s t-test, p < 0.05.
Plotting of clone sizes and cell types across time points matched the standing paradigm that
gliogenesis accelerates during E15.5–E17.5 with larger clones containing glia compared to earlier TAM
inductions during neurogenesis (Figure 2b,c). Moreover, in the F/+ cortices there was a significant
increase in number and percentages of red WT glia concomitant with the near complete abolition of
green Egfr-null glia, both of which reside in an Egfr-het background (Figure 2b,c). In this dosage model,
it became clear that Egfr is sufficient (via analysis of red MADM cells in F/+ cortices) and required
(via analysis of green MADM cells in F/+ cortices) for induction and/or expansion of a glial fate in the
dorsolateral cortices.
Laminar positioning of clonal neurons in the upper (UL) and deep (DL) layers of the +/+
dorsolateral cortices also followed the established developmental patterns of cortical neuronal layering
(DL early, UL late; Figure S3). Accordingly, neuron production was proportionally similar in UL and
DL in E11.5-induced +/+ cortices, but more UL neurons were quantified in E15.5, E16.5, and E17.5
clones. In comparison, astrocyte production was similar in UL and DL in both E11.5 and E15.5
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clones, with more astrocytes found in the DL at E16.5, and more UL astrocytes at E17.5 in +/+ cortices.
As described earlier, oligodendrocytes were predominately found in the DL, with almost none found
in the UL. In comparison, F/+ clones exhibited significant disruptions in the laminar positioning of
both neurons and glia in F/+ clones, with more UL neurons found in E11.5, E15.5, and E16.5 inductions,
whereas few (if any) neurons could be found in E17.5 clones. In F/+ clones, the average number of
red (WT) UL neurons was significantly greater and more variable than the average number of green
(Egfr-null) UL neurons at E11.5, whereas the opposite pattern was consistently produced at the later
induction times (greater numbers of green UL neurons than red UL neurons). This finding suggests
that the double dosage of Egfr in red WT F/+ MADM cells, relative to their environment, facilitates the
final rounds of neuronal production resulting in their depletion, such that almost no UL red neurons are
observable in F/+ clones inducted after E15.5 (also see later). Interestingly, total astrocyte production in
F/+ clones failed to exhibit the same pattern seen in +/+ clones with no differential distributions found
between UL and DL at any time (Figure S3). Oligodendrocytes were restricted to the DL in F/+ clones,
as they were in +/+ cortices; however, red MADM oligodendrocytes were significantly more abundant
than green cells in F/+ sublineages (Figure S3). Thus, layering of astrocytes appears to largely follow
the inside-out pattern seeding of neurons with a delay, and the F/+ genotype disrupts this pattern with
no discernable differences in UL and DL positioning.
3.2. Distinct Clone Types and Their Responsiveness to Egfr Dosage in the Dorsolateral Cortices
Beyond general observations based on standard statistical analyses, MADM uniquely provides
data on clone sizes (total cells per clone) and clone symmetries (relative cell counts in red and green
lineages), in addition to cell type information. As such, the multidimensional MADM datasets require
in-depth computational analyses of the relationship between total clonal output and the fates of the
two daughter lineages. Clones were first categorized as containing only neurons (N), only glia (G),
or a mix of the two (Mix), regardless of whether the MADM cells were red or green (Figure 3a).
Results revealed a clear distinction in the percentages of clone types across the different induction
time points (Figure 3b). Aligned with emergence of gliogenesis late during cortical development,
a significant number of G clones were found in the cortex of E15.5, E16.5, and E17.5 TAM-induced
embryos, whereas none could be found in E11.5 clones. This finding suggests the absence of
glia-restricted progenitors in the early developing cortex and that glia largely originate from previously
neurogenic lineages. Overall, these findings are consistent with the lineage-progression model of
cortical development [1,43–45], and match our previous report on the deleterious effects of Egfr deletion
on gliogenesis in MADM populations in the cortex [33]. Mix clones were present more often in F/+
than +/+ cortices at E11.5 (but not at E15.5 or E16.5; Figure 3b). However, there were significantly fewer
F/+ Mix clones than +/+ Mix clones at E17.5 (Chi-square test: E17.5, p = 0.001; Figure 3b). This finding
indicated that a significant reduction in proportions of Mix F/+ clones in response to Egfr deletion
occurs late during gliogenesis (between E16.5 and E17.5). Moreover, it appears that early E11.5 derived
F/+ clones are more likely to progress into gliogenesis following neurogenesis (leading to more Mix
clones), which may lead to more G lineages observed at the later time points. Thus, it is unlikely that the
progression into gliogenesis from neurogenesis occurs in a pre-determined subset of clones, but rather
more clones can become gliogenic if a loss of glia is somehow sensed in clonally-related populations.
When analyzing total MADM neurons per clone (without separating green and red cells) in +/+
cortices, there was no significant difference between N and Mix clones at any time point (blue bars,
Figure 3c). Neuron totals in F/+ N and Mix clones were also similar in E11.5 and E15.5 cortices, whereas N
clones were absent at E16.5 and Mix clones were missing at E17.5 (Figure 3c). Interestingly, when we
compared red and green neurons separately, the Mix F/+ clones at E11.5 produced significantly more
red (WT) neurons than E11.5 +/+ Mix clones (Figure 3c; rank-sum test, p = 0.026), whereas N +/+ and
N F/+ clones failed to produce significantly different numbers of red neurons at E11.5. In contrast,
numbers of neurons per clone at E11.5 were similar between green F/+ (Egfr-null) and green +/+
(WT) cells in both N and Mix clones (Figure 3c; rank-sum test; p = 0.52 and p = 0.26, respectively).
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The neuronal numbers at later time points were small with fewer neuron-containing clones; however,
significant differences between red and green populations of neurons were observed mostly in F/+ Mix
clones (Figure 3c). Thus, Egfr deletion has no effect on neuronal expansion in green MADM clones,
whereas the elevated expansion of red MADM glia coincides with significantly more red neurons in F/+
lineages at E11.5. This finding suggests that elevated production of glia in the red MADM population
coincides with a significant increase in neuronal output early during neurogenesis.
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Glial production w s relatively consistent across clone ypes and MADM i uction times in
+/+ cortices (Figure 3d). G clo es produ d 12 ± 1 glia at E15.5, 13 ± 1 glia a E16.5, and 12 ± 1 at
E17.5, and Mix cl es produced 8 ± 1 glia at E11.5, 11 ± 2 glia at E15.5 and 12 ± 2 at E17. , matching
our past clonal analysis [33]. The exception to this consistency appeared in E16.5 +/+ Mix clones,
ich produced 27 ± 5 gli , a significantly larger number of glia than Mix +/+ clones at E15.5 an
E17.5 (Wilcoxon Rank Sum Test, p < 0.05 for both), as well as E16.5 +/+ G lones (Wilcoxon Rank Sum
Test, p < 0.01). Similar comparisons in F/+ cortices revealed that glial production was also consiste t in
G clones (18 ± 3 glia at E15.5, 21 ± 4 glia at E16.5, 24 ± 4 at E17.5; Figure 3d). Mix F/+ clones produced
more glia at E16.5 than at E11.5 or E15.5, although the diffe nce failed to reach significance, likely due
to the large varianc in the cell numbers (19 ± 3 glia at E11.5, 15 ± 5 glia at E15.5, 35 ± 10 a E16.5,
Wilcoxon Rank Sum Test, p = 0.16 and p = 0.17, r spectively). The difference between glial production
in Mix F/+ and G F/+ clones at E16.5 was also not significant, unlike in the +/+ case (p = 0.20, Figure 3d).
At E17.5, while some Mix clones were present in +/+ cortices, n ne were observed in F/+ ortices.
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Mix clones at E15.5 and E16.5 failed to produce a significantly different distribution of total glia
per clone in response to deletion of Egfr in F/+ cortices, despite the decrease in glial production in the
Egfr-null population (green) and its increase in WT clones (red) (Figure 3d; rank-sum test, E15.5 p = 0.41,
E16.5 p = 0.66). However, Mix E11.5 F/+ clones contained an elevated number of glia as compared
with Mix E11.5 +/+ clones (rank-sum test, p = 0.002), and E17.5 F/+ cortices contained no Mix clones.
This suggests that the apparent compensatory overexpansion of red WT glia in response to Egfr deletion
in their green siblings occurs early during the gliogenic switch. In contrast with the general behavior
of Mix clones, G clones produced a larger average number of glia in F/+ than in +/+ clones at all
time-points (E15.5, p = 0.047; E16.5, p = 0.026, E17.5, p = 0.0014; Figure 3d). While it is unclear why an
increase in total glial production appears selective to G clones and not Mix clones, it is conceivable that
Mix clones that produce most of their glia in the red sublineages give the robust appearance of “glial
only” clones. Alternatively, the possibility that some G clones may originate from outside the cortical
progenitor zones could explain their absence in E11.5 inductions and their differential response to Egfr
deletion in later induction ages.
3.3. Gliogenic Clones Expand Asymmetrically in the Dorsolateral Cortices
Given the power of MADM in delineating subclones derived from sibling progenitors with
definitive genetic labels, we next assessed the asymmetry of clonal expansion during gliogenesis
(Figure 4; Figure S4). First, we noted that a number of clones contained only red or only green cells
(neurons and/or glia) with no cells found in the other lineage. We labeled these clones as “one-sided
asymmetric.” Of the G and Mix clones with cells (either neurons or glia) in both red and green
MADM lineages, we categorized each clone based on its numbers of red and green glia: “symmetric,”
with >3 glia in both red and green lineages, “two-sided asymmetric,” either with >3 glia in one lineage
and 1–3 in the other or with 0 glia in one lineage and >0 in the other, or “small” having 1–3 glia in both
lineages (Figure 4a). The second definition of two-sided asymmetric clones does not make the clone
one-sided asymmetric despite having zero glia in the other lineage; in this case, there were neurons in
the lineage with zero glia. These categorizations were also applied to the red and green neurons in
N and Mix clones; Mix clones thus were given two symmetry categories, one for their neurons and
the other for their glia (separated in Figure 4a). Analyses of clone sizes, symmetries, and clone size
distributions were then performed across different subsets of the data grouped or separated by MADM
induction time, genotype, and clone type.
For neuron-containing clones, we separated clones into categories by their symmetries and time
points, then compared the neuron production of +/+ versus F/+ clones in each category (Figure 4a).
The only significant difference between +/+ and F/+ neuron production was seen in small E16.5 clones
(p = 0.0154). We note that neuron production in small clones, although minor, was significantly different
between +/+ and F/+ when grouping all time points together (+/+, 3 ± 0.2 neurons; F/+, 4 ± 0.3 neurons,
p < 0.01). Interestingly, when a similar comparison between +/+ and F/+ neuron production was
performed for groups of clones separated by symmetry and clone type (N or Mix), the only significant
difference was seen in small Mix clones (p < 0.01). These results suggest that neuron production within
each symmetry group is comparable overall between +/+ and F/+ cortices, but Egfr deletion affects the
output of small neuron-containing clones. Since small clones are likely the product of MADM-based
labeling of a progenitor near the end of its lineage progression, these combined results suggest that
Egfr deletion increases the capacity for neuron production at the end of neurogenesis. As a reminder,
Egfr deletion results in the blockade of glial production while double dosage of Egfr in the same clone
results in overproduction of glia (especially astrocytes) in the dorsolateral cortices. Thus, the effects on
neurogenesis in small clones likely reflect early effects of Egfr-null progenitors on their WT siblings.
We repeated the category-analysis for glia-containing clones in +/+ versus F/+ cortices. With all
time points and clone types combined, the total glia per clone were significantly elevated in all categories
of F/+ clones except in small clones relative to the same categories in +/+ clones (symmetric: 26 ± 2 vs.
47 ± 8, one-sided asymmetric: 10 ± 1 vs. 18 ± 2, two-sided asymmetric: 11 ± 1 vs. 20 ± 2, p < 0.01 in all
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cases; Figure 4a). We know from earlier analyses that this elevation is due to an increase in numbers
of red WT MADM glia in F/+ cortices. When broken down by time, significant differences between
glial production in +/+ and F/+ cortices were specifically observed in E16.5 symmetric, E15.5 and
E17.5 one-sided asymmetric, and E11.5 and E17.5 two-sided asymmetric clones (p < 0.05 in all cases;
Figure 4a). Small glia-containing clones produced similar total glia per clone in +/+ and F/+ cortices
at all times. When examining +/+ versus F/+ clones by symmetry category and clone type (G and
Mix), we found that while Mix clones were similar in their glial production in any of the symmetry
groups, it was significantly different for symmetric, one-sided asymmetric, and two-sided asymmetric
G clones (p < 0.05 in all cases). Thus, all symmetry categories of glia-containing clones, except the
small category, were affected by the deletion of Egfr in the green MADM subclone and its double
dosage in their sibling red WT MADM cells. The increase in glial production in each of these symmetry
groups can specifically be tied to G clones rather than Mix clones. To examine this further, rather than
categorizing clones into symmetry categories based on absolute numbers of cells, we plotted clonal
symmetries using percentages of cells in each of the clone’s smaller subclone (0–50%). The results
showed a tendency for more asymmetric distributions of cells between subclones, particularly in G
clones (Figure 4b).
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Figure 4. Analysis of clonal AD data in Neuron-containing and Glia-containing clones in the
dorsolateral cortices. (a) Analysis of symmetry in clones at different time points and genotypes. Data are
percentages of clones that form the different categories of clones as indicated. Numbers in the bars
indicate the numbers of clones that fall into each category. Charts present numbers of cells per clone for
each category of neuron-containing and glia-containing clones for all time points combined. Data are
mean ± sem. *, rank-sum test, p < 0.05. (b) Percentages of clones across a gradient of asymmetry
depicted on the x-axes (0 = one-sided asymmetric; 50 = symmetric) in +/+ and F/+ cortices. Data are
shown separately for each clone type and for all clones combined. The majority of G clones are
one-sided asymmetric in both genotypes (green and red MADM cells are combined).
Taken together, the findings from our clonal symmetry analyses indicate that unlike neurogenesis,
gliogenesis is highly asymmetric at the clonal level, resulting in highly variable distributions of clone
types and sizes. In contrast to its effects on neurogenesis, Egfr deletion in our MADM labeling paradigm
and dosage model increases average overall glial output in the red F/+ MADM subclones, but has no
discernible effect on clones that have only one or two remaining divisions.
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3.4. Gliogenic Clones Exhibit a Stochastic Mode of Expansion in the Dorsolateral Cortices
Given the differences between neurogenesis and gliogenesis and the robust changes in gliogenesis
from E15.5 to E17.5, we next established criteria to categorize clonal expansion in our MADM data sets
as deterministic or stochastic. Rather than mathematically defining this difference by setting arbitrary
thresholds for degrees of variability in number of cells produced, we adopted the assumption that the
two processes are mutually exclusive. Therefore, we can define stochastic events as “not deterministic”
and datasets that fail to reveal the hallmark mathematical patterns of a deterministic mechanism
can be assigned as stochastic. Previous studies have noted that patterns in the distribution of clone
sizes (i.e., histogram of total neurons or total glia per clone) can indicate deterministic or stochastic
patterns at the clonal level. For example, the distribution of neurons produced in a stochastic model
with assigned probabilities for types of cell division (Galton–Watson process) has a shape similar to a
geometric distribution, with the specific scaling of the distribution determined by the cell division
probabilities [38]. On the other hand, the proposed deterministic process of neurogenesis was associated
with a multi-Gaussian distribution whose peaks are equally spaced (Figure 5a; [1]). We therefore
considered several models as possible matches for the distribution of glia per clone in our E15.5,
E16.5 and E17.5 induction data: a one-stage stochastic model [38], a more complex two-stage stochastic
model, a multi-Gaussian with equally spaced peaks, and a multi-Gaussian with unequally spaced
peaks. For each of these models, we tested their goodness of fit to several glial clone size distributions:
+/+ G clones, +/+ Mix clones, +/+ G and Mix clones, and the same for the F/+ genotype, considering only
clones containing 50 or less glia.
We found that a one-stage stochastic model sufficiently represented the distribution of +/+ G
clones, whereas the deterministic equally-spaced multi-Gaussian sufficiently represented +/+ Mix
clones. Interestingly, the distribution of +/+ G and Mix clones was not represented well by the
stochastic models or the equally-spaced multi-Gaussian, but instead the best fit was produced by the
multi-Gaussian with unequally spaced peaks (Figure 5b). The uneven spacing of frequent glial clone
sizes indicates a lack of predictable behavior across the full population of gliogenic clones—we label
this pattern as stochastic. Applying the same multi-Gaussian curve fitting to the F/+ data revealed that
there was not a large difference in the small glial clone sizes compared to the +/+ data, as measured by
the location of the first two Gaussian peaks, but the larger clones contribute to the difference between
the clonal output of the two genotypes (Figure 5b).
We also took a second approach in identifying deterministic or stochastic patterns by examining
the clonal symmetries for fractal characteristics (Figure 5c,d). In neurogenesis, it was shown that the
ratio of neurons in the larger to smaller subclone was preserved over time for “symmetric” clones
having four or more neurons in each subclone [1]. By extension, since clone sizes decreased predictably
over successive MADM induction points during neurogenesis, this ratio was also preserved over
total clone size. We note that this self-similarity of clonal symmetries throughout neurogenesis is
characteristic of fractal patterns. Interestingly, the preserved ratio during neurogenesis was ~1.6
(Figure 5c), corresponding to the golden ratio and hinting at clonal proliferation capacity being
described by Fibonacci numbers [46]. This pattern was observed for neuron production in both E11.5
+/+ and F/+ clones (Figure 5c). In contrast, we found that gliogenic clones categorized as symmetric
(>3 glia in both red and green sublineages) tended to have a wider range of relative symmetry ratios
between the larger and smaller sublineages, often greater than 2:1. Additionally, we found that larger
symmetric gliogenic clones (>25 total glia with at least 4 glia on each side) tended to have greater
ratios of larger to smaller subclones than smaller symmetric gliogenic clones (<12 total glia with at
least 4 glia on each side) in both +/+ and F/+ cortices (Figure 5d). Thus, unlike neurogenesis, subclone
ratios were not preserved between larger and smaller gliogenic clones, with the smaller symmetric
gliogenic clones tending to approach more consistent ratios between 2:1 and 1:1. This suggests far
more stochasticity in MADM subclone fate during the expansion phase of gliogenesis, with a possible
shift to more predictable symmetric divisions as a clone reaches the end of gliogenesis. Thus, the lack
of preserved symmetries in gliogenic clones does not point to the level of organization seen in the
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fractal patterns of neurogenesis. This level of disorganization was even more profound in F/+ cortices,
where unusually large red glia-containing MADM clones are present (Figure 5d). Taken together,
our multiple analytical approaches suggest that while clonal neurogenesis resembles a deterministic
pattern of expansion, gliogenesis may lack the cell intrinsic machinery that dictates defined numbers
of divisions at the level of individual clones.
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Figure 5. Gliogenesis exhibits a stochastic pattern of clonal expansion in the cortex. (a) Gaussian curve
fitting for analysis of size distribution of clones versus their normalized frequency for early neurogenic
clones (E10.5–E14.5). Values for the histogram and Gaussian curves were extracted manually
using the WebPlotDigitizer (https://automeris.io/WebPlotDigitizer/citation.html) from Gao et al. [1].
(b) Gaussian curve fitting for analysis of size distribution of clones versus their normalized frequency
for gliogenic clones (E15.5–E17.5). (c) Scatterplot presenting the size (number of cells) of larger versus
smaller sibling subclones of individual clones during the neurogenic period at E11.5 in +/+ and F/+
cortices. (d) Scatterplots presenting the size (number of cells) of larger versus smaller sibling subclones
of individual clones during the gliogenic period in +/+ and F/+ cortices. White, black, and gray dots
with error bars represent mean ± sem, faded dots indicate individual clones, and the slopes indicate
ratio boundaries as indicated in both (c,d).
4. Discussion
Figure 6 is a summary of our current findings. Our results indicate that clonally derived glial cells
in the cortical parenchyma (layers II–VI) largely consist of astrocytes with only few oligodendrocytes
in the deep layers of the P30 mouse dorsolateral cortex. This finding does not rule out the possibility
that oligodendrocytes and their precursors occupy the upper layers of the cortex earlier during
postnatal maturation. Such distribution patterns would require that oligodendrocytes either die,
migrate away from the maturing cortical layers, and/or transdifferentiate into astrocytes or other cell
types following their function as oligodendrocytes. In fact, several waves of proliferation during and
after the switch from neurogenesis to gliogenesis give rise to distinct populations of oligodendrocytes,
with the early population (which is likely derived from the ventral telencephalon) disappearing during
early postnatal periods [47,48]. Moreover, as indicated in the results, we excluded SEZ/WM cells
Cells 2020, 9, 2662 14 of 18
from our analysis since the cellular populations in that tissue are highly complex and require detailed
analyses with the aid of molecular markers and additional induction time points during early postnatal
days. In addition, given that cells may continue to migrate tangentially in the SEZ/WM into early
adulthood, clonality of cells in this tissue must be established using additional approaches such as
genetic bar-coding methods (e.g., [49]). As an example, the ependymal cells found in our clones were
extremely small in number and often appeared as pairs, suggesting their derivation from terminal
symmetric divisions. However, given the likely planar expansion of the ependymal layer relative to the
overlying WM and cortical plate, it is possible that many clonally-related ependymal cells were missed
in our analysis and should be reexamined in ependymal wholemounts, possibly in combination with
the use of bar-coding methods.
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Figure 6. Summary: MADM enabled labeling of sparse clones in dorsolateral cortices of +/+ and F/+
mice reveals switch to gliogenesis around E15 followed by seeding of glia without involvement of
glia-restricted clones from early neurogenic period. Allelic Egfr dosage analysis using MADM with a
conditional allele for Egfr revealed that the background cells and their genotype (Egfr-heterozygous)
influence Egfr-null (green) and wild type (WT, red) MADM siblings. Comparison of cortical MADM
progeny in +/+ and F/+ cortices exposed a dosage response in glial populations whereby WT MADM
cells expand to compensate for loss of glia in their MADM green siblings. Neurogenic clones exhibit
symmetric and deterministic patterns of expansion, whereas clonal expansion during gliogenesis is
highly asymmetric and stochastic.
We also found high diversity in the total cellular output and division patterns of glia-containing
clones in dorsolateral cortices. Clones containing only glia appear during the gliogenic period and are
not present in the early developing cortex, suggesting the absence of glia-restricted clones during early
corticogenesis. The employment of MADM was instrumental as we found that the observed types of
glial clones are effected by the deletion of Egfr in one clonal sibling, resulting in cell-autonomous loss
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of gliogenic potential. Interestingly, the clonal siblings to the Egfr-null progenitors that have double the
dosage of Egfr relative to background non-MADM cells appear to somehow sense the loss of Egfr either
through cell–cell interactions or through cell competition mechanisms. This compensation results not
only in the balancing out of total populations of glia in the cortex, but also appears to over-expand
beyond what is seen in +/+ cortices. The precise mechanisms underlying the relationship between
sibling pairs of progenitors remain to be determined, although a past study has suggested the existence
of physical interactions (e.g., gap junctions) between pairs of sibling progenitors in the developing
cortex [50].
Our findings also reveal that glial production was consistent over time during embryonic
development, except at E16.5. This suggests the absence of a defined period of significant symmetric
proliferation during gliogenesis, similar to the early period of symmetric expansion during cortical
neurogenesis. It was surprising that the MADM cells induced at E11.5 or E15.5 failed to capture the
significant elevation in glial production documented in E16.5 Mix clones. That is, since MADM should
theoretically track all cells in a lineage after the initial MADM-recombined cell divides, evidence for
later clonal behaviors in earlier labeled lineages was expected if all later clones are descendants from
earlier ones. As such, it remains unclear whether later gliogenic lineages are descended from ones
labeled earlier with MADM, which may suggest that some later clones (E16.5 and E17.5) may have
originated from outside the cortex (e.g., the ventral telencephalon) and thus were not observed in
earlier inductions.
Finally, we provided evidence that gliogenic expansion occurs in a stochastic manner in individual
clones, which is in contrast to the predictable and deterministic neurogenic clonal expansion that
occurs earlier during cortical development [1]. Specifically, the distribution of glia per clone was
consistent with a multi-Gaussian model with unequally spaced peaks. The latter property of our model
supports the notion of stochastic gliogenic expansion, in contrast to the simpler set of underlying clonal
expansion rules and equally spaced population-level multi-Gaussian peaks exhibited in neurogenic
clonal expansion [1]. The biological significance of this stochasticity remains unclear at this juncture;
however, it is tempting to compare it to the variability reported for clonal expansion in non-neuronal
tissues that can regenerate throughout life [2–5]. The mechanisms that underlie the stochasticity
inherent to glial expansion and how it differs from deterministic patterns of neurogenic clonal expansion
remain to be determined. Whether clonal principles described in the current study apply to pathogenic
gliogenesis in the damaged or diseased cortex at various ages remains to be thoroughly studied.
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MADM cells.
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